甲状腺相关性免疫眼眶病与高眼压

Thyroid-associated orbitopathy and ocular hypertension

甲状腺相关性免疫眼眶病（TAO）是临床上一大类疾病。1897年首次报道了TAO可引起高眼压。以后众多作者发现TAO患者眼球在原位及向上转时,均发生眼压升高。据报道约24％TAO患者有高眼压,重者（1.8％）有视神经受压症状,引起继发性青光眼,甚至失明。综述了TAO引起高眼压的病因、临床表现、辅助检查、诊断、治疗及预后。

Objective Thyroid-associated orbitopathy (TAO) is a common disease. It was first reported that TAO could result in ocular hypertension in 1897. Then, it was found that intraocular pressure of patients with TAO (eye ball in primary position and upgaze) was raised. It was reported that 24% patients with TAO had high intraocular pressure,1. 8% patients had the significance of optic nerve involvement and progression to glaucomatous damage, even some patients were blind. Ocular hypertension suffered from TAO affected the living activities of the patients. Ophthalmologists are work hard to discover the causes and therapy of ocular hypertension suffered from TAO. This review discussed the causes, symptoms, diagnose, examinations and therapy of ocular hypertension with TAO.